A Rare Encounter: Severe Hypertension and Hypokalemia Due to an Apparent Mineralocorticoid Excess
- 1 Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
- 2 Department of Medicine (Nephrology), Adan hospital, Ahmadi City, Kuwait
Abstract
Background : Apparent mineralocorticoid excess syndrome (AME) is an extremely rare autosomal-recessive genetic disorder due to deficiency in 11-beta-hydroxysteroid dehydrogenase enzyme type 2 isoform (11-beta-HSD2) that converts cortisol to cortisone. The resultant high cortisol level (100-fold higher than aldosterone) avidly binds to and activates the mineralocorticoid receptors leading to hypertension and hypokalemia. Case : A 14-year-old girl presented with severe hypertension, unprovoked hypokalemia with high urinary potassium output, and metabolic alkalosis. She did not have a history of parenteral disease, chronic licorice ingestion and lung tumors by FDG-PET scan. Diagnosis was established by; 1) a high 24-hour urinary cortisol to cortisone ratio (>18), 2) low serum levels of renin, aldosterone, 11-beta-HSD and adrenocorticotrophic hormones, and 3) genetic testing showing homozygous pathogenic variants in HSD11B2 gene. Treatment : With low-salt diet and daily Amlodipine 5 mg, Amiloride 50 mg and Spironolactone 50 mg, stabilized her disorders up to 6 months of follow-up. Conclusion : AME should be considered in children with severe hypertension and unprovoked hypokalemia.
- Tse, G., Li, K.H.C., Cheung, C.K.Y., Letsas, K.P., Bhardwaj, A., Sawant, A.C., et al . (2021) Arrhythmogenic Mechanisms in Hypokalaemia: Insights from Pre-Clinical Models. Frontiers in Cardiovascular Medicine , 8, Article 620539. https://doi.org/10.3389/fcvm.2021.620539
- Palmer, B.F. (2015) Regulation of Potassium Homeostasis. Clinical Journal of the American Society of Nephrology , 10, 1050-1060. https://doi.org/10.2215/cjn.08580813
- Rapsomaniki, E., Timmis, A., George, J., Pujades-Rodriguez, M., Shah, A.D., Denaxas, S., et al . (2014) Blood Pressure and Incidence of Twelve Cardiovascular Diseases: Lifetime Risks, Healthy Life-Years Lost, and Age-Specific Associations in 1.25 Million People. The Lancet , 383, 1899-1911. https://doi.org/10.1016/s0140-6736(14)60685-1
- Blanchard, A. (2023) Pathophysiologic Approach in Genetic Hypokalemia: An Update. Annales d ’ Endocrinologie , 84, 298-307. https://doi.org/10.1016/j.ando.2022.11.005
- Walker, B.R., Campbell, J.C., Fraser, R., Stewart, P.M. and Edwards, C.R.W. (1992) Mineralocorticoid Excess and Inhibition of 11 β ‐Hydroxysteroid Dehydrogenase in Patients with Ectopic ACTH Syndrome. Clinical Endocrinology , 37, 483-492. https://doi.org/10.1111/j.1365-2265.1992.tb01478.x
- Cui, Y., Tong, A., Jiang, J., Wang, F. and Li, C. (2016) Liddle Syndrome: Clinical and Genetic Profiles. The Journal of Clinical Hypertension , 19, 524-529. https://doi.org/10.1111/jch.12949
- Chrousos, G. (2011) Q&A: Primary Generalized Glucocorticoid Resistance. BMC Medicine , 9, Article No. 27. https://doi.org/10.1186/1741-7015-9-27
- White, P.C., New, M.I. and Dupont, B. (1987) Congenital Adrenal Hyperplasia. New England Journal of Medicine , 316, 1580-1586. https://doi.org/10.1056/nejm198706183162506
- Pacak, K. and Eisenhofer, G. (2007) An Assessment of Biochemical Tests for the Diagnosis of Pheochromocytoma. Nature Clinical Practice Endocrinology & Metabolism , 3, 744-745. https://doi.org/10.1038/ncpendmet0615
- Geller, D.S., Farhi, A., Pinkerton, N., Fradley, M., Moritz, M., Spitzer, A., et al . (2000) Activating Mineralocorticoid Receptor Mutation in Hypertension Exacerbated by Pregnancy. Science , 289, 119-123. https://doi.org/10.1126/science.289.5476.119
- Fan, P., Lu, Y., Yang, K., Zhang, D., Liu, X., Tian, T., et al . (2020) Apparent Mineralocorticoid Excess Caused by Novel Compound Heterozygous Mutations in HSD11B2 and Characterized by Early-Onset Hypertension and Hypokalemia. Endocrine , 70, 607-615. https://doi.org/10.1007/s12020-020-02460-9